Bausch Health
BHC
#4665
Rank
โ‚ฌ2.08 B
Marketcap
5,58ย โ‚ฌ
Share price
-3.27%
Change (1 day)
-10.95%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -2,81ย โ‚ฌ

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -2,78ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 0,36ย โ‚ฌ an increase over its 2024 EPS that were of -0,10ย โ‚ฌ.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,81ย โ‚ฌ-879.16%
20250,36ย โ‚ฌ-450%
2024-0,10ย โ‚ฌ-92.59%
2023-1,39ย โ‚ฌ160.89%
2022-0,53ย โ‚ฌ-76.64%
2021-2,28ย โ‚ฌ68.45%
2020-1,35ย โ‚ฌ-68.91%
2019-4,35ย โ‚ฌ-57.11%
2018-10,15ย โ‚ฌ-272.22%
20175,89ย โ‚ฌ-199.29%
2016-5,94ย โ‚ฌ798.7%
2015-0,66ย โ‚ฌ-128.31%
20142,33ย โ‚ฌ-204.62%
2013-2,23ย โ‚ฌ602.7%
2012-0,32ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,23ย โ‚ฌ-91.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,82ย โ‚ฌ-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA